Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Schlieren photography on freely flying hawkmoth.

Liu Y, Roll J, Van Kooten S, Deng X.

Biol Lett. 2018 May;14(5). pii: 20180198. doi: 10.1098/rsbl.2018.0198.

PMID:
29769300
2.

Engagement in online pain self-management improves pain in adults on medication-assisted behavioral treatment for opioid use disorders.

Wilson M, Finlay M, Orr M, Barbosa-Leiker C, Sherazi N, Roberts MLA, Layton M, Roll JM.

Addict Behav. 2018 Apr 27. pii: S0306-4603(18)30364-2. doi: 10.1016/j.addbeh.2018.04.019. [Epub ahead of print]

PMID:
29731244
3.

Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness.

Oluwoye O, Skalisky J, Burduli E, Chaytor NS, McPherson S, Murphy SM, Herron J, Hirchak K, Burley M, Ries RK, Roll JM, McDonell MG.

Contemp Clin Trials. 2018 Apr 20;69:92-98. doi: 10.1016/j.cct.2018.04.010. [Epub ahead of print]

PMID:
29680318
4.

Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment.

Barbosa-Leiker C, McPherson S, Layton ME, Burduli E, Roll JM, Ling W.

Am J Drug Alcohol Abuse. 2018;44(4):488-496. doi: 10.1080/00952990.2018.1458234. Epub 2018 Apr 19.

PMID:
29672167
5.

A randomized clinical trial to evaluate the efficacy of contingency management for treatment of waterpipe tobacco addiction.

Shishani K, Odom-Maryon T, Roll JM.

Am J Addict. 2018 Apr;27(3):202-209. doi: 10.1111/ajad.12708. Epub 2018 Mar 23.

PMID:
29569328
6.

Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management.

Orr MF, Lederhos Smith C, Finlay M, Martin SC, Brooks O, Oluwoye OA, Leickly E, McDonell M, Burduli E, Barbosa-Leiker C, Layton M, Roll JM, McPherson SM.

Behav Pharmacol. 2018 Mar 20. doi: 10.1097/FBP.0000000000000379. [Epub ahead of print]

PMID:
29561290
7.

Sociodemographic Characteristics, Patterns of Crack Use, Concomitant Substance Use Disorders, and Psychiatric Symptomatology in Treatment-Seeking Crack-Dependent Individuals in Brazil.

Miguel AQC, Madruga CS, Cogo-Moreira H, Yamauchi R, Simões V, Da Silva CJ, Abdalla RR, McDonell M, McPherson S, Roll JM, Mari JJ, Laranjeira RR.

J Psychoactive Drugs. 2018 Mar 12:1-6. doi: 10.1080/02791072.2018.1436729. [Epub ahead of print]

PMID:
29528783
8.

Crack cocaine users views regarding treatment with contingency management in Brazil.

Miguel AQC, Madruga CS, Simões V, Yamauchi R, da Silva CJ, Abdalla RR, McDonell M, McPherson S, Roll JM, Mari JJ, Laranjeira RR.

Subst Abuse Treat Prev Policy. 2018 Feb 12;13(1):7. doi: 10.1186/s13011-018-0144-7.

9.

Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals.

Miguel AQC, Madruga CS, Cogo-Moreira H, Yamauchi R, Simões V, Ribeiro A, da Silva CJ, Fruci A, McDonell M, McPherson S, Roll JM, Laranjeira RR.

Exp Clin Psychopharmacol. 2017 Dec;25(6):466-472. doi: 10.1037/pha0000147.

PMID:
29251975
10.

Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.

Oluwoye O, Hirchak K, Leickly E, Skalisky J, McPherson S, Srebnik D, Roll JM, Ries RK, McDonell MG.

Psychiatry Res. 2017 Nov 29;260:233-235. doi: 10.1016/j.psychres.2017.11.070. [Epub ahead of print]

PMID:
29220679
11.

Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness.

Leickly E, Skalisky J, Oluwoye O, McPherson SM, Srebnik D, Roll JM, Ries RK, McDonell MG.

Subst Abus. 2017 Nov 21:1-4. doi: 10.1080/08897077.2017.1391926. [Epub ahead of print]

PMID:
29161228
12.

Decreases in smoking during treatment for methamphetamine-use disorders: preliminary evidence.

McPherson S, Orr M, Lederhos C, McDonell M, Leickly E, Hirchak K, Oluwoye OA, Murphy SM, Layton M, Roll JM.

Behav Pharmacol. 2018 Jun;29(4):370-374. doi: 10.1097/FBP.0000000000000349.

PMID:
29035917
13.

Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders.

Skalisky J, Leickly E, Oluwoye O, McPherson SM, Srebnik D, Roll JM, Ries RK, McDonell MG.

Cannabis Cannabinoid Res. 2017 Jun 1;2(1):133-138. doi: 10.1089/can.2017.0006. eCollection 2017.

14.

Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.

McDonell MG, Leickly E, McPherson S, Skalisky J, Hirchak K, Oluwoye O, Srebnik D, Roll JM, Ries RK.

Am J Addict. 2017 Oct;26(7):673-675. doi: 10.1111/ajad.12558. Epub 2017 Aug 18.

PMID:
28833832
15.

Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.

McDonell MG, Skalisky J, Leickly E, Orr MF, McPherson S, Roll J, Hill-Kapturczak N, Javors M.

Psychol Addict Behav. 2017 Aug;31(5):608-613. doi: 10.1037/adb0000293. Epub 2017 Jul 17.

PMID:
28714726
16.

A Randomized Controlled Trial of a Citywide Emergency Department Care-Coordination Program to Reduce Prescription Opioid-Related Visits: An Economic Evaluation.

Murphy SM, Howell D, McPherson S, Grohs R, Roll J, Neven D.

J Emerg Med. 2017 Aug;53(2):186-194. doi: 10.1016/j.jemermed.2017.02.014. Epub 2017 Apr 12.

PMID:
28410960
17.

Use of cell phones and computers for health promotion and tobacco cessation by American Indian college students in Montana.

Dotson JA, Nelson LA, Young SL, Buchwald D, Roll J.

Rural Remote Health. 2017 Jan-Mar;17(1):4014. Epub 2017 Mar 22.

18.

A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.

McDonell MG, Leickly E, McPherson S, Skalisky J, Srebnik D, Angelo F, Vilardaga R, Nepom JR, Roll JM, Ries RK.

Am J Psychiatry. 2017 Apr 1;174(4):370-377. doi: 10.1176/appi.ajp.2016.16050627. Epub 2017 Jan 31. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

19.

A Randomized Controlled Trial of a Citywide Emergency Department Care Coordination Program to Reduce Prescription Opioid Related Emergency Department Visits.

Neven D, Paulozzi L, Howell D, McPherson S, Murphy SM, Grohs B, Marsh L, Lederhos C, Roll J.

J Emerg Med. 2016 Nov;51(5):498-507. doi: 10.1016/j.jemermed.2016.06.057. Epub 2016 Sep 10.

20.

Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial.

Miguel AQ, Madruga CS, Cogo-Moreira H, Yamauchi R, Simões V, da Silva CJ, McPherson S, Roll JM, Laranjeira RR.

Psychol Addict Behav. 2016 Aug;30(5):536-543. Epub 2016 Jul 21.

21.

Association Between Prescription Opioid Use and Biomarkers of Kidney Disease in US Adults.

Barbosa-Leiker C, McPherson S, Daratha K, Alicic R, Short R, Dieter B, Chaytor N, Roll J, Tuttle KR.

Kidney Blood Press Res. 2016;41(4):365-73. doi: 10.1159/000443436. Epub 2016 Jun 20.

22.

JAR3D Webserver: Scoring and aligning RNA loop sequences to known 3D motifs.

Roll J, Zirbel CL, Sweeney B, Petrov AI, Leontis N.

Nucleic Acids Res. 2016 Jul 8;44(W1):W320-7. doi: 10.1093/nar/gkw453. Epub 2016 May 27.

23.

Self-reported smoking effects and comparative value between cigarettes and high dose e-cigarettes in nicotine-dependent cigarette smokers.

McPherson S, Howell D, Lewis J, Barbosa-Leiker C, Bertotti Metoyer P, Roll J.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):301-7. doi: 10.1097/FBP.0000000000000226.

PMID:
26886210
24.

A culturally-tailored behavioral intervention trial for alcohol use disorders in three American Indian communities: Rationale, design, and methods.

McDonell MG, Nepom JR, Leickly E, Suchy-Dicey A, Hirchak K, Echo-Hawk A, Schwartz SM, Calhoun D, Donovan D, Roll J, Ries R, Buchwald D.

Contemp Clin Trials. 2016 Mar;47:93-100. doi: 10.1016/j.cct.2015.12.010. Epub 2015 Dec 17.

25.

Nurses' Perceptions of Caring for Childbearing Women who Misuse Opioids.

Shaw MR, Lederhos C, Haberman M, Howell D, Fleming S, Roll J.

MCN Am J Matern Child Nurs. 2016 Jan-Feb;41(1):37-42. doi: 10.1097/NMC.0000000000000208.

PMID:
26658534
26.

Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients.

McDonell MG, Skalisky J, Leickly E, McPherson S, Battalio S, Nepom JR, Srebnik D, Roll J, Ries RK.

Drug Alcohol Depend. 2015 Dec 1;157:184-7. doi: 10.1016/j.drugalcdep.2015.10.004. Epub 2015 Oct 9.

27.

Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials.

McPherson S, Brooks O, Barbosa-Leiker C, Lederhos C, Lamp A, Murphy S, Layton M, Roll J.

J Subst Abuse Treat. 2016 Feb;61:18-25. doi: 10.1016/j.jsat.2015.08.008. Epub 2015 Sep 21.

28.

An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorder.

Mamey MR, Barbosa-Leiker C, McPherson S, Burns GL, Parks C, Roll J.

Exp Clin Psychopharmacol. 2015 Dec;23(6):422-7. doi: 10.1037/pha0000047. Epub 2015 Sep 21.

29.

Reinforcement Schedule Effects on Long-Term Behavior Change.

Chudzynski J, Roll JM, McPherson S, Cameron JM, Howell DN.

Psychol Rec. 2015 Jun 1;65(2):347-353.

30.

Identifying novel sequence variants of RNA 3D motifs.

Zirbel CL, Roll J, Sweeney BA, Petrov AI, Pirrung M, Leontis NB.

Nucleic Acids Res. 2015 Sep 3;43(15):7504-20. doi: 10.1093/nar/gkv651. Epub 2015 Jun 29.

31.

Empowering Patients with Persistent Pain Using an Internet-based Self-Management Program.

Wilson M, Roll JM, Corbett C, Barbosa-Leiker C.

Pain Manag Nurs. 2015 Aug;16(4):503-14. doi: 10.1016/j.pmn.2014.09.009. Epub 2015 Jun 15.

PMID:
26088940
32.

An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness.

Murphy SM, McDonell MG, McPherson S, Srebnik D, Angelo F, Roll JM, Ries RK.

Drug Alcohol Depend. 2015 Aug 1;153:293-9. doi: 10.1016/j.drugalcdep.2015.05.004. Epub 2015 May 14.

33.

Kinesthetic illusions attenuate experimental muscle pain, as do muscle and cutaneous stimulation.

Gay A, Aimonetti JM, Roll JP, Ribot-Ciscar E.

Brain Res. 2015 Jul 30;1615:148-156. doi: 10.1016/j.brainres.2015.04.041. Epub 2015 Apr 29.

PMID:
25935692
34.

Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003.

Barbosa-Leiker C, McPherson S, Mamey MR, Burns GL, Layton ME, Roll J, Ling W.

Drug Alcohol Depend. 2015 Jul 1;152:218-23. doi: 10.1016/j.drugalcdep.2015.03.036. Epub 2015 Apr 11.

35.

Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.

Lowe JM, McDonell MG, Leickly E, Angelo FA, Vilardaga R, McPherson S, Srebnik D, Roll J, Ries RK.

Alcohol Clin Exp Res. 2015 May;39(5):905-10. doi: 10.1111/acer.12699. Epub 2015 Apr 10.

36.

High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry.

Leickly E, McDonell MG, Vilardaga R, Angelo FA, Lowe JM, McPherson S, Srebnik D, Roll JM, Ries RK.

Am J Drug Alcohol Abuse. 2015 May;41(3):246-50. doi: 10.3109/00952990.2015.1011743. Epub 2015 Feb 19.

37.

Dysregulation of the epigenome in human breast cancer: contributions of gene-specific DNA hypermethylation to breast cancer pathobiology and targeting the breast cancer methylome for improved therapy.

Sandhu R, Roll JD, Rivenbark AG, Coleman WB.

Am J Pathol. 2015 Feb;185(2):282-92. doi: 10.1016/j.ajpath.2014.12.003. Epub 2014 Dec 23. Review.

PMID:
25541331
38.

Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.

Murphy SM, Dweik D, McPherson S, Roll JM.

Am J Drug Alcohol Abuse. 2015 Jan;41(1):88-92. doi: 10.3109/00952990.2014.983274.

39.

Prevalence of persistent pain in the U.S. adult population: new data from the 2010 national health interview survey.

Kennedy J, Roll JM, Schraudner T, Murphy S, McPherson S.

J Pain. 2014 Oct;15(10):979-84. doi: 10.1016/j.jpain.2014.05.009.

PMID:
25267013
40.

A 'missing not at random' (MNAR) and 'missing at random' (MAR) growth model comparison with a buprenorphine/naloxone clinical trial.

McPherson S, Barbosa-Leiker C, Mamey MR, McDonell M, Enders CK, Roll J.

Addiction. 2015 Jan;110(1):51-8. doi: 10.1111/add.12714. Epub 2014 Oct 16.

41.

Preliminary findings: Contingency management targeting psycho-stimulant use results in secondary decreases in smoking for severely mentally ill adults.

McDonell M, McPherson S, Vilardaga R, Srebnik D, Angelo FN, Leickly E, Saxon AJ, Roll J, Ries R.

Am J Addict. 2014 Jul-Aug;23(4):407-10. doi: 10.1111/j.1521-0391.2013.12114.x. Epub 2013 Sep 13.

42.

Rapid response team implementation and in-hospital mortality*.

Salvatierra G, Bindler RC, Corbett C, Roll J, Daratha KB.

Crit Care Med. 2014 Sep;42(9):2001-6. doi: 10.1097/CCM.0000000000000347.

PMID:
24743041
43.

Urban and rural utilization of evidence-based practices for substance use and mental health disorders.

Dotson JA, Roll JM, Packer RR, Lewis JM, McPherson S, Howell D.

J Rural Health. 2014 Summer;30(3):292-9. doi: 10.1111/jrh.12068. Epub 2014 Apr 6.

PMID:
24702675
44.

Association of co-occurring serious mental illness with emergency hospitalization in people with chronic kidney disease.

McPherson S, Barbosa-Leiker C, Daratha K, Short R, McDonell MG, Alicic R, Roll J, Tuttle K.

Am J Nephrol. 2014;39(3):260-7. doi: 10.1159/000360095. Epub 2014 Mar 19.

PMID:
24663040
45.

Young adult waterpipe smokers: Smoking behaviors and associated subjective and physiological effects.

Shishani K, Howell D, McPherson S, Roll J.

Addict Behav. 2014 Jun;39(6):1113-9. doi: 10.1016/j.addbeh.2014.03.010. Epub 2014 Mar 12.

46.

The effect of serious mental illness on the risk of rehospitalization among patients with diabetes.

Chwastiak LA, Davydow DS, McKibbin CL, Schur E, Burley M, McDonell MG, Roll J, Daratha KB.

Psychosomatics. 2014 Mar-Apr;55(2):134-43. doi: 10.1016/j.psym.2013.08.012. Epub 2013 Dec 22.

47.

Three-dimensional vortex wake structure of flapping wings in hovering flight.

Cheng B, Roll J, Liu Y, Troolin DR, Deng X.

J R Soc Interface. 2013 Dec 11;11(91):20130984. doi: 10.1098/rsif.2013.0984. Print 2014 Feb 6.

48.

Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study.

McPherson S, Packer RR, Cameron JM, Howell DN, Roll JM.

Am J Addict. 2014 Jan-Feb;23(1):15-20. doi: 10.1111/j.1521-0391.2013.12059.x. Epub 2013 May 24.

PMID:
24313236
49.

Determinants of buprenorphine treatment for opioid dependence.

Murphy SM, Fishman PA, McPherson S, Dyck DG, Roll JR.

J Subst Abuse Treat. 2014 Mar;46(3):315-9. doi: 10.1016/j.jsat.2013.09.003. Epub 2013 Oct 25.

PMID:
24209382
50.

Psychometric properties of the adjective rating scale for withdrawal across treatment groups, gender, and over time.

Barbosa-Leiker C, McPherson S, Mamey MR, Burns GL, Roll J.

J Subst Abuse Treat. 2014 Feb;46(2):251-6. doi: 10.1016/j.jsat.2013.08.020. Epub 2013 Sep 24.

Supplemental Content

Support Center